Forbes published the rating of “100 largest private enterprises of Ukraine”. Farmak is the only pharmaceutical manufacturer that got into this list.
Today Farmak is a leader of the pharmaceutical market with a 5.9% share. The medicinal products manufactured by the Company are presented in fourteen therapeutic groups. The portfolios mainly consist of anti-cold, endocrinological, gastroenterological, cardiological and neurological medicinal products. Farmak launches about 20 new medicines annually; they are multicomponent, modern products necessary for millions of people living both in our country and abroad. Currently about 100 medicinal products are being developed. The Company employs more than 2,700 people.
Farmak sells 40 registered medicinal products in 13 European countries. This is a record for Ukrainian pharmaceutical industry. Since the beginning of the pandemic, there has been a sharp increase in the demand for medicinal products for the complex therapy of COVID-19 patients. This has made some of the Company’s medicinal products extremely in demand. And although not all of them are registered in the EU countries, in the situation of abnormal demand, the company obtained import permits not only to the Great Britain, Sweden, France, Germany, Poland, but also to Australia, New Zealand, Mexico and Singapore. In addition, the Company has provided record shipments of complex injection medicinal products to Israel. “Such conditions became possible for us due to the fact that Farmak’s quality system meets the EU standards, and the manufacturing is certified by European inspections,” said Volodymyr Kostiuk in his interview for the publication.
